Hyaluronidase activity is modulated by complexing with various polyelectrolytes including hyaluronan

Matrix Biology

Volumn 27, Issue 3, 2008, Pages 242-253

  Deschrevel, Brigitte ^a   Lenormand, Hélène ^a   Tranchepain, Frédéric ^a   Levasseur, Nicolas ^a   Astériou, Trias ^a   Vincent, Jean Claude ^a  

^a UNIVERSITÉ DE ROUEN   (France)

Author keywords

Bovine serum albumin; Enzymatic activation; Enzymatic inhibition; Hyaluronan; Hyaluronan protein complex; Hyaluronidase; Hydrolysis kinetics

Indexed keywords

ALBUMIN; HYALURONIC ACID; HYALURONIDASE; POLYELECTROLYTE;

ANIMAL TISSUE; ARTICLE; CATALYSIS; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); ELECTRICITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; IN VIVO STUDY; INHIBITION KINETICS; KINETICS; MODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; TURBIDIMETRY;

ANIMALS; CATALYSIS; CATTLE; ELECTROLYTES; GENE EXPRESSION REGULATION; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; KINETICS; SERUM ALBUMIN; SPECTROPHOTOMETRY; TIME FACTORS; UMBILICAL VEINS;

BOVINAE;

EID: 40849083609     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.matbio.2007.11.002     Document Type: Article

References (67)

1. Aronson Jr. N.N., and Davidson E.A. Lysosomal hyaluronidase from rat liver: II. Properties. J. Biol. Chem. 242 (1967) 441-444
2. Astériou, T., 2002. Cinétique de la réaction d'hydrolyse du hyaluronane catalysée par la hyaluronidase testiculaire bovine. Transposition à une hyaluronidase extraite de tumeurs cancéreuses humaines. Dr. Sc. Thesis, Rouen, France.
3. Astériou T., Deschrevel B., Delpech B., Bertrand P., Bultelle F., Merai C., and Vincent J.-C. An improved assay for the N-acetyl-d-glucosamine reducing ends of polysaccharides in the presence of proteins. Anal. Biochem. 293 (2001) 53-59
4. Astériou T., Gouley F., Deschrevel B., and Vincent J.-C. Influence of substrate and enzyme concentrations on hyaluronan hydrolysis kinetics catalyzed by hyaluronidase. In: Kennedy J.F., Phillips G.O., and Williams P.A. (Eds). Hyaluronan vol. 1 (2002), Woodhead Publishing, Wrexham, Wales 249-252
5. Astériou T., Vincent J.-C., Tranchepain F., and Deschrevel B. Inhibition of hyaluronan hydrolysis catalysed by hyaluronidase at high substrate concentration and low ionic strength. Matrix Biol. 25 (2006) 166-174
6. Berriaud N., Milas M., and Rinaudo M. Characterization and properties of hyaluronic acid (hyaluronan). In: Dumitriu S. (Ed). Polysaccharides: structural diversity and functionnal versatility (1998), Marcel Dekker Inc., New York 313-334
7. Bertrand P., Girard N., Duval C., d'Anjou J., Chauzy C., Menard J.F., and Delpech B. Increased hyaluronidase levels in breast tumor metastases. Int. J. Cancer 73 (1997) 327-331
8. Bitter T., and Muir H.M. A modified uronic acid carbazole reaction. Anal. Biochem. 4 (1962) 330-334
9. Bollet A., Bonner W., and Nance J. The presence of hyaluronidase in various mammalian tissues. J. Biol. Chem. 238 (1963) 3522-3527
10. Catterall J.B. Hyaluronic acid, cell adhesion and metastasis. Cancer J. 8 (1995) 320-324
11. Cleland R.L., Wang J.L., and Detweiler D.M. Polyelectrolyte properties of sodium hyaluronate. I Salt exclusion in sodium chloride solution. Macromolecules 15 (1982) 382-386
12. Csóka A.B., Frost G.I., and Stern R. The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol. 20 (2001) 499-508
13. Deed R., Rooney P., Kumar P., Norton J.D., Smith J., Freemont A.J., and Kumar S. Early response gene signaling is induced by angiogenic oligosaccharides of hyaluronan in endothelial cells. Inhibition by non-angiogenic, high-molecular-weight hyaluronan. Int. J. Cancer 71 (1997) 251-256
14. Delpech B., Girard N., Bertrand P., Courel M.-N., Chauzy C., and Delpech A. Hyaluronan: fundamental principles and applications in cancer. J. Intern. Med. 242 (1997) 41-48
15. Denuziere A., Ferrier D., and Domard A. Interactions between chitosan and glycosaminoglycans (chondroitin sulfate and hyaluronic acid): physicochemical and biological studies. Ann. Pharm. Fr. 58 (2000) 47-53
16. Diccianni M.B., Mistry M.J., Hug K., and Harmony J.A. Inhibition of phospholipase A2 by heparin. Biochim. Biophys. Acta 1046 (1990) 242-248
17. Dische Z. A new specific color reaction of hexuronic acid. J. Biol. Chem. 167 (1947) 189-198
18. Dorfman A., and Ott M.L. A turbidimetric method for the assay of hyaluronidase. J. Biol. Chem. 172 (1948) 367-375
19. Fiszer-Szafarz B. Demonstration of a new hyaluronidase inhibitor in serum of cancer patients. Proc. Soc. Exp. Biol. Med. 129 (1968) 300-302
20. Gacesa P., Savitsky M.J., Dodgson K.S., and Olavesen A.H. A recommended procedure for the estimation of bovine testicular hyaluronidase in the presence of human serum. Anal. Biochem. 118 (1981) 76-84
21. Girish K.S., and Kemparaju K. Inhibition of Naja naja venom hyaluronidase by plant-derived bioactive components and polysaccharides. Biochem. (Moscow) 70 (2005) 948-952
22. Gold E.W. An interaction of albumin with hyaluronic acid and chondroitin sulfate: a study of affinity chromatography and circular dichroism. Biopolymers 19 (1980) 1407-1414
23. Gold E.W. Purification and properties of hyaluronidase from human liver. Biochem. J. 205 (1982) 69-74
24. Grymonpré K.R., Staggemeier B.A., Dubin P.L., and Mattison K.W. Identification by integrated computer modeling and light scattering studies of an electrostatic serum albumin-hyaluronic acid binding site. Biomacromolecules 2 (2001) 422-429
25. Hobby G.L., Dawson M.H., Meyer K., and Chaffee E. The relationship between spreading factor and hyaluronidase. J. Exp. Med. 73 (1941) 109-123
26. Isoyama T., Thwaites D., Selzer M.G., Carrey R.I., Barbucci R., and Lokeshwar V.B. Differential selectivity of hyaluronidase inhibitors towards acidic and basic hyaluronidases. Glycobiology 16 (2006) 11-21
27. Kass E.H., and Seastone C.V. The role of the mucoid polysaccharide (hyaluronic acid) in the virulence of group A hemolytic streptococci. J. Exp. Med. 79 (1944) 319-330
28. Kennedy J.F., Phillips G.O., and Williams P.A. Hyaluronan (2002), Woodhead, Publishing Ltd., Abington, Cambridge, England
29. Kolarova M. Host-tumor relationship XXXIII. Inhibitor of hyaluronidase in blood serum of cancer patients. Neoplasma 22 (1975) 435-439
30. Kumar S., West D.C., Ponting J.M., and Gattamaneni H.R. Sera of children with renal tumours contains low-molecular-mass hyaluronic acid. Int. J. Cancer 44 (1989) 445-448
31. Laidler K.J. The Chemical Kinetics of Enzyme Action (1958), Clarendon Press, Oxford
32. Laurent T.C. Biochemistry of hyaluronan. Acta Oto-laryngol. Suppl. 442 (1987) 7-24
33. Lokeshwar V.B., Lokeshwar B.L., Pham H.T., and Block N.L. Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression. Cancer Res. 56 (1996) 651-657
34. Lokeshwar V.B., Oebek C., Soloway M.S., and Block N.L. Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer. Cancer Res. 57 (1997) 773-777
35. Maingonnat C., Victor R., Bertrand P., Courel M.-N., Maunoury R., and Delpech B. Activation and inhibition of human cancer cell hyaluronidase by proteins. Anal. Biochem. 268 (1999) 30-34
36. Maksimenko A.V., Petrova M.L., Tischenko E.G., and Schechilina Y.V. Chemical modification of hyaluronidase regulates its inhibition by heparin. Eur. J. Pharm. Biopharm. 51 (2001) 33-38
37. 2 myotoxins. Toxicon 37 (1999) 199-215
38. Meyer K., and Rapport M. Hyaluronidases. Adv. Enzymol. 13 (1952) 199-236
39. Mio K., Carrette O., Maibach H.I., and Stern R. Evidence that the serum inhibitor of hyaluronidase may be a member of the inter-α-inhibitor family. J. Biol. Chem. 275 (2000) 32413-32421
40. Mio K., and Stern R. Inhibitors of the hyaluronidases. Matrix Biol. 21 (2002) 31-37
41. Mathews M.B., and Dorfman A. Inhibition of hyaluronidase. Physiol. Rev. 35 (1955) 381-402
42. Peters T. Serum albumin. In: Putman F.W. (Ed). The plasma protein vol. 1 (1975), Academic Press, New York 133-181
43. Prehm P. Hyaluronate is synthesized at plasma membranes. Biochem. J. 220 (1984) 597-600
44. Reissig J., Strominger J., and Leloir J. A modified colorimetric method for the estimation of N-acetylamino sugars. J. Biol. Chem. 217 (1955) 959-966
45. Robertson W., Ropes M., and Bauer W. Mucinase: a bacterial enzyme which hydrolyzes synovial fluid mucin and other mucins. J. Biol. Chem. 133 (1940) 261-276
46. Rooney P., Kumar S., Ponting J., and Wang M. The role of hyaluronan in tumour neovascularization. Int. J. Cancer 60 (1995) 632-636
47. Scott D., Coleman P.J., Mason R.M., and Levick J.R. Interaction of intraarticular hyaluronan and albumin in the attenuation of fluid drainage from joints. Arthritis Rheum. 43 (2000) 1175-1182
48. Shimada E., and Matsumura G. Degradation process of hyaluronic acid by Streptomyces hyaluronidase. J. Biochem. (Tokyo) 88 (1980) 1015-1023
49. Stern R. Hyaluronan catabolism: a new metabolic pathway. Eur. J. Cell Biol. 83 (2004) 317-325
50. Stern R. Hyaluronan metabolism: a major paradox in cancer biology. Pathol. Biol. 53 (2005) 372-382
51. Stern R., Asari A.A., and Sugahara K.N. Hyaluronan fragments: an information-rich system. Eur. J. Cell Biol. 85 (2006) 699-715
52. Stern R., and Jedrzejas M.J. Hyaluronidases: their genomics, structures and mechanisms of action. Chem. Rev. 106 (2006) 818-839
53. Sugahara K.N., Murai T., Nishinakamura H., Kawashima H., Saya H., and Miyasaka M. Hyaluronan oligosaccharides induce CD44 cleavage and promote cell migration in CD44-expressing tumor cells. J. Biol. Chem. 278 (2003) 32259-32265
54. Sugahara K.N., Hirata T., Hayasaka H., Stern R., Murai T., and Miyasaka M. Tumor cells enhance their own CD44 cleavage and motility by generating hyaluronan fragments. J. Biol. Chem. 281 (2006) 5861-5968
55. Toida T., Ogita Y., Suzuki A., Toyoda H., and Imanari T. Inhibition of fully O-sulfonated glycosaminoglycans. Arch. Biochem. Biophys. 370 (1999) 176-182
56. Tolksdorf S., McCready M.H., McCullagh D.R., and Schwenk E. The turbidimetric assay of hyaluronidase. J. Lab. Clin. Med. 34 (1949) 74-89
57. Toole B.P. Hyaluronan promotes the malignant phenotype. Glycobiology 12 (2002) 37-42
58. Tranchepain F., Deschrevel B., Courel M.-N., Levasseur N., Le Cerf D., Loutelier-Bourhis C., and Vincent J.-C. A complete set of hyaluronan fragments obtained from hydrolysis catalyzed by hyaluronidase: application to studies of hyaluronan mass distribution by simple HPLC devices. Anal. Biochem. 348 (2006) 232-242
59. U.S. Pharmacopeia. 22nd Edn, U.S. Pharmacopeia, U.S. Pharmacopeial Convention Inc., Rockville, MD (1990) 1774
60. Van Damme M.P.I., Moss J.M., Murphy W.H., and Preston B.N. Binding properties of glycoasminoglycans to lysozyme - effect of salt and molecular weight. Arch. Biochem. Biophys. 310 (1994) 16-24
61. Victor R., Maingonat C., Chauzy C., Bertrand P., Olivier A., Maunoury R., Gioanni J., and Delpech B. Production of hyaluronidase by cultured human tumor cells. C. R. Acad. Sci. III 320 (1997) 805-810
62. Vincent J.-C., Asteriou T., and Deschrevel B. Kinetics of hyaluronan hydrolysis catalysed by hyaluronidase. Determination of the initial reaction rate and the kinetic parameters. J. Biol. Phys. Chem. 3 (2003) 35-44
63. Wang Y.F., Gao J.Y., and Dubin P.L. Protein separation via polyelectrolyte coacervation: selectivity and efficiency. Biotechnol. Prog. 12 (1996) 356-362
64. Weigel P.H., Hascall V.C., and Tammi M. Hyaluronan synthases. J. Biol. Chem. 272 (1997) 13997-14000
65. West D.C., and Kumar S. The effect of hyaluronan and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp. Cell Res. 183 (1989) 179-196
66. West D.C., and Kumar S. Hyaluronan and angiogenesis. In: Evered D., and Whelan J. (Eds). The Biology of Hyaluronan vol. 143 (1989), John Wiley and Sons, Chichester 187-207
67. Xu S., Yamanaka J., Sato S., Miyama I., and Yonese M. Characteristics of complexes composed of sodium hyaluronate and bovine serum albumin. Chem. Pharm. Bull. 48 (2000) 779-783